Drug and diagnosis match On-label prescriptions receive the highest approval probability
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice
Giorgi Pkhakadze, MD, MPH, PhD GMJ News Desk The US Food and Drug Administration has issued a safety communication warning about potential premature battery depletion in Boston Scientific's Accolade pacemaker devices, which may require earlier-than-expected device replacement
Im not a medical professional, but there is logic that aligns with these reported patient experiences
A low level is associated with anemia and this is another reason to identify the cause of anemia, which could be iron deficiency, B12, or folate deficiency
Not everyone pursuing tirzepatide is focused on the number on the scale